InvestorsHub Logo
Followers 2
Posts 158
Boards Moderated 0
Alias Born 03/22/2020

Re: None

Wednesday, 12/02/2020 1:22:13 PM

Wednesday, December 02, 2020 1:22:13 PM

Post# of 16443
Today's message from Mr. Barhhizer, as posted, has caused a flurry of
disappointment as reflected in the share price drop but there are prospects for more developments that the patient can bring. Namely FDA approval and EAU (emergency approval use). I'm holding.

NanoLogix, a small, innovative, historically under-capitalized biotechnology company, has developed this technology through funding and research by the CEO and two Directors, with a keen awareness of the importance of this development relative to the current pandemic. The Company has also benefited from the assistance of a small number of long-term shareholders with lasting faith in the Company’s work and potential. Gratitude is expressed to all involved for their contributions. Thanks also to Gwen Acker Wood, IP Attorney, for her superb attention to detail and experience in patent work.
Bret Barnhizer
Nanologix Incorporated